We are live on ! Find out more
FTH

Faeth Therapeutics
FTH

10 hedge funds and large institutions have $600K invested in Faeth Therapeutics in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.11% less ownership

Funds ownership: 0.38% → 0.28% (-0.11%)

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

21% less capital invested

Capital invested by funds: $760K → $600K (-$160K)

50% less funds holding

Funds holding: 20 → 10 (-10)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
10
Holders Change
-10
Holders Change %
-50%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$4.13K
2
SS
SBI Securities
Japan
+$1.03K
3
UBS Group
UBS Group
Switzerland
+$93
4
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
+$7

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$69.9K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$59.4K
3
BFM
Boothbay Fund Management
New York
-$42.8K
4
Northern Trust
Northern Trust
Illinois
-$10.2K
5
State Street
State Street
Massachusetts
-$10.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$250K -$1.36K -189 -0.6%
IC
2
Ikarian Capital
Texas
$193K -$7 -1 -0%
CCM
3
Catalio Capital Management
New York
$126K -$7 -1 -0%
UBS Group
4
UBS Group
Switzerland
$18.4K +$93 +13 +0.6%
Raymond James Financial
5
Raymond James Financial
Florida
$6.01K – – –
Bank of America
6
Bank of America
North Carolina
$5K +$4.13K +576 +8,229%
SS
7
SBI Securities
Japan
$1.28K +$1.03K +144 +2,880%
JP Morgan Chase
8
JP Morgan Chase
New York
$275 -$22 -3 -9%
Morgan Stanley
9
Morgan Stanley
New York
$86 -$3.24K -451 -98%
BNP Paribas Financial Markets
10
BNP Paribas Financial Markets
France
$77 +$7 +1 +13%
Renaissance Technologies
11
Renaissance Technologies
New York
– -$69.9K -8,865 Closed
Geode Capital Management
12
Geode Capital Management
Massachusetts
– -$59.4K -7,535 Closed
BFM
13
Boothbay Fund Management
New York
– -$42.8K -5,433 Closed
Northern Trust
14
Northern Trust
Illinois
– -$10.2K -1,299 Closed
State Street
15
State Street
Massachusetts
– -$10.2K -1,289 Closed
CAM
16
Cresset Asset Management
Illinois
– -$7.75K -984 Closed
NAS
17
NWF Advisory Services
California
– -$6.51K -826 Closed
TRCT
18
Tower Research Capital (TRC)
New York
– -$2.13K -270 Closed
Barclays
19
Barclays
United Kingdom
– -$1.01K -128 Closed
Citigroup
20
Citigroup
New York
– -$49 -6 Closed

FTH Hedge Fund Activity: Q2 2025 in Review

10 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q2 2025, worth a combined $600K — down 21% from $760K a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of FTH and 0 opened new positions — a net loss of 10 holders — while 5 trimmed existing stakes and 4 added.

The largest buyer was Bank of America, adding an estimated $4.13K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $69.9K sold.

  • 10 institutional investors held Faeth Therapeutics (FTH) as of Q2 2025, down from 20 in Q1 2025.
  • Funds reported $600K of Faeth Therapeutics stock for Q2 2025, down 21% quarter-over-quarter.
  • 0 funds opened new Faeth Therapeutics positions in Q2 2025 and 10 closed out, a net change of -10 holders.
  • The largest Faeth Therapeutics buyer in Q2 2025 was Bank of America, an estimated $4.13K added.
  • The largest Faeth Therapeutics seller in Q2 2025 was Renaissance Technologies, an estimated $69.9K sold.

Based on aggregated 13F filings for Q2 2025.